Management of the ageing eyebrow and forehead: An objective dose-response study with botulinum toxin

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 6, 2006, Pages 711-716

  Levy, Jean L ^a   Pons, F ^b   Jouve, E ^c  

^a Centre Laser Dermatologique   (France)

^b Biophymed   (France)

^c TIMONE HOSPITAL   (France)

Author keywords

3D skin imaging; Botulinum toxin; BTX A; Forehead wrinkles

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOLOGY; DRUG DOSE REGIMEN; DRUG INJECTION VOLUME; EYEBROW; FOREHEAD; FRANCE; HEIGHT; HUMAN; PHOTOMETRY; PRIORITY JOURNAL; PRIVATE PRACTICE; PROSPECTIVE STUDY; SKIN DISEASE; STANDARDIZATION; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL IMAGING; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WRINKLE;

ADULT; AGED; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS, TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; EYEBROWS; FOLLOW-UP STUDIES; FOREHEAD; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SKIN AGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745278040     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01605.x     Document Type: Article

References (11)

1. Honeck P, Weiss C, Sterry W, Rzany B, Gladys study group. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br J Dermatol 2003; 149: 306-310.
2. Carruthers JA, Lowe NJ, Menter MA et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002; 46: 840-849.
3. Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. J Am Acad Dermatol 2002; 47: 834-840.
4. Levy JL, Servant JJ, Jouve E. Botulinum toxin A: A 9-month clinical and 3D in vivo profilometric crow's feet wrinkle formation study. J Cosmet Laser Ther 2004; 6: 16-20.
5. Huilgol SC, Carruthers A, Carruthers JD. Raising eyebrows with botulinum toxin. Dermatol Surg 1999; 25: 373-375; discussion 376.
6. Huang W, Rogachefsky AS, Foster JA. Browlift with botulinum toxin. Dermatol Surg 2000; 26: 55-60.
7. Nemoto M, Uchinuma E, Yamashina S. Three-dimensional analysis of forehead wrinkles. Aesthetic Plast Surg 2002; 26: 10-16.
8. Chen AH, Frankel AS. Altering brow contour with botulinum toxin. Facial Plast Surg Clin North Am 2003; 11: 457-464.
9. Redaelli A, Forte R. How to avoid brow ptosis after forehead treatment with botulinum toxin. J Cosmet Laser Ther 2003; 5: 220-222.
10. Fagien S. Botulinum toxin type A for facial aesthetic enhancement: Role in facial shaping. Plast Reconstr Surg 2003; 112: 6S-18S; discussion 19S-20S.
11. Kokoska MS, Amato JB, Hollenbeak CS, Glaser DA. Modifications of eyebrow position with botulinum exotoxin A. Arch Facial Plast Surg 2002; 4: 244-247.